Search results
Results from the Health.Zone Content Network
Dimethyl sulfide (DMS) or methylthiomethane is an organosulfur compound with the formula (CH 3) 2 S. The simplest thioether , it is a flammable liquid that boils at 37 °C (99 °F) and has a characteristic disagreeable odor.
Aspen Pharmacare Holdings Limited is a public multinational pharmaceutical company headquartered in uMhlanga, South Africa. [7] Founded in 1997, [8] it listed on the Johannesburg Stock Exchange (JSE) in 1998, [9] and purchased South African Druggists in 1999 before expanding into international markets. [10]
May 17, 2024 at 9:58 AM. CAPE TOWN, South Africa (AP) — An exhaustive rescue operation to find missing construction workers trapped in the rubble of a collapsed building in South Africa ended ...
R511M (2021) [1] Number of employees. 2223 (2021) [2] Parent. Bidvest Group. Website. www.adcock.com. Adcock Ingram is a South African pharmaceutical manufacturer listed on the Johannesburg Stock Exchange. Adcock Ingram manufactures and markets healthcare products to both the private and public sectors.
Dimethyl sulfate ( DMS) is a chemical compound with formula (CH 3 O) 2 SO 2. As the diester of methanol and sulfuric acid, its formula is often written as ( CH 3) 2 SO 4 or Me 2 SO 4, where CH 3 or Me is methyl. Me 2 SO 4 is mainly used as a methylating agent in organic synthesis .
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. [10] The company's key focus areas include paediatrics , cardiovascular , anti-infectives , diabetology , asthma and anti-tuberculosis .
AECI's principal manufacturing sites are located in Johannesburg (mining solutions and specialty chemicals), Sasolburg (specialty chemicals), Durban (specialty chemicals) in South Africa. AECI is a specialty product and services group of companies which claims to provide "value-adding solutions to customers through science, technology and ...
Medicines and Related Substance 1997. South Africa's Medicines and Related Substance 1997 is a law enacted a compulsory license in order to fight HIV/AIDS epidemic. The intent of the Act was to reduce drug prices by allowing generic substitution of off-patent drugs, the parallel importation of on-patent drugs as well as price transparency.